文献速递儿童青少年精神心境障碍精神分裂症与精神病性障碍

复发性拷贝数变异与精神障碍风险的人群基于研究

Population-Based Risk of Psychiatric Disorders Associated With Recurrent Copy Number Variants.
PubMed 文献 · JAMA Psychiatry · 2024-01-01

该基因关联研究基于丹麦iPSYCH病例-队列样本(92 531例患者与50 625名随机亚队列),估计27个常染色体复发性拷贝数变异(rCNV)的精神障碍患病率与风险。多数rCNV相关风险为中等且跨ADHD、ASD、SSD高度相关;Prader-Willi/Angelman综合征重复的ASD风险HR为20.8(95%CI 7.9-55),无rCNV与MDD风险增加相关。

要点

  • 多数rCNV与ADHD、ASD、SSD的风险增加为中等且高度相关。
  • Prader-Willi/Angelman综合征重复的ASD风险HR 20.8(95%CI 7.9-55)。
  • 无rCNV与重性抑郁障碍风险增加相关。

核心结论

  • 本研究发现若干rCNV的患病率高于既往估计,且带来的精神障碍风险低于既往估计。
  • 多数病例对照研究高估了rCNV相关精神障碍风险,可能源于选择偏倚。
  • 在遗传学日益临床应用的背景下,这些结果凸显了基于人群的风险估计对遗传预测的重要性。

研究设计与样本

  • 本研究为基因关联研究,分析丹麦iPSYCH病例-队列样本中1981-2008年出生、随访至2015年的个体。
  • 样本包括所有因ADHD、ASD、双相障碍、MDD或SSD住院出院诊断的个体(n=92 531)及从源人群随机抽取的亚队列(n=50 625)。
  • 暴露为27个常染色体rCNV位点的缺失和重复携带状态,由新生儿血样单核苷酸变异微阵列基因分型确定。
  • 数据分析时间为2021年1月至2023年8月。

主要发现

  • 共在64 735名出生时指定为男性(53.8%)和55 512名出生时指定为女性(46.2%)个体中识别出3547个rCNV,随访结束时年龄7.0至34.7岁(平均21.8岁)。
  • 多数观察到的rCNV相关ADHD、ASD或SSD风险增加为中等,且这些障碍的风险估计高度相关。
  • Prader-Willi/Angelman综合征重复的ASD相关风险较高(HR 20.8;95%CI 7.9-55)。
  • 无rCNV与MDD风险增加相关。
  • rCNV相关风险与位点大小和基因约束正相关,但与剂量类型无关。

关键数值与推荐

  • Prader-Willi/Angelman综合征重复的ASD风险HR为20.8(95%CI 7.9-55)。
  • 无rCNV与MDD风险增加相关。
  • rCNV相关风险与位点大小和基因约束正相关,但与剂量类型无关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 多数病例对照研究高估rCNV相关精神障碍风险,可能源于选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Recurrent copy number variants (rCNVs) have been associated with increased risk of psychiatric disorders in case-control studies, but their population-level impact is unknown. OBJECTIVE: To provide unbiased population-based estimates of prevalence and risk associated with psychiatric disorders for rCNVs and to compare risks across outcomes, rCNV dosage type (deletions or duplications), and locus features. DESIGN, SETTING, AND PARTICIPANTS: This genetic association study is an analysis of data from the Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH) case-cohort sample of individuals born in Denmark in 1981-2008 and followed up until 2015, including (1) all individuals (n = 92 531) with a hospital discharge diagnosis of attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder (ASD), bipolar disorder, major depressive disorder (MDD), or schizophrenia spectrum disorder (SSD) and (2) a subcohort (n = 50 625) randomly drawn from the source population. Data were analyzed from January 2021 to August 2023. EXPOSURES: Carrier status of deletions and duplications at 27 autosomal rCNV loci was determined from neonatal blood samples genotyped on single-nucleotide variant microarrays. MAIN OUTCOMES AND MEASURES: Population-based rCNV prevalence was estimated with a survey model using finite population correction to account for oversampling of cases. Hazard ratio (HR) estimates and 95% CIs for psychiatric disorders were derived using weighted Cox proportional hazard models. Risks were compared across outcomes, dosage type, and locus features using generalized estimating equation models. RESULTS: A total of 3547 rCNVs were identified in 64 735 individuals assigned male at birth (53.8%) and 55 512 individuals assigned female at birth (46.2%) whose age at the end of follow-up ranged from 7.0 to 34.7 years (mean, 21.8 years). Most observed increases in rCNV-associated risk for ADHD, ASD, or SSD were moderate, and risk estimates were highly correlated across these disorders. Notable exceptions included high ASD-associated risk observed for Prader-Willi/Angelman syndrome duplications (HR, 20.8; 95% CI, 7.9-55). No rCNV was associated with increased MDD risk. Also, rCNV-associated risk was positively correlated with locus size and gene constraint but not with dosage type. Comparison with published case-control and community-based studies revealed a higher prevalence of deletions and lower associated increase in risk for several rCNVs in iPSYCH2015. CONCLUSIONS AND RELEVANCE: This study found that several rCNVs were more prevalent and conferred less risk of psychiatric disorders than estimated previously. Most case-control studies overestimate rCNV-associated risk of psychiatric disorders, likely because of selection bias. In an era where genetics is increasingly being clinically applied, these results highlight the importance of population-based risk estimates for genetics-based predictions.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Vaez M, Montalbano S, Calle Sánchez X, et al. Population-Based Risk of Psychiatric Disorders Associated With Recurrent Copy Number Variants. JAMA Psychiatry. 2024. PMID: 38922630. doi:10.1001/jamapsychiatry.2024.1453

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。